Tazemetostat in combination with topotecan and pembrolizumab in patients with recurrent small cell lung cancer

被引：0
|
作者：
Desai, Parth Anil
Takahashi, Nobuyuki
Lissa, Delphine
Nichols, Samantha
Sciuto, Linda
Abel, Melissa Lauren
Schroeder, Brett
Schultz, Christopher
Steinberg, Seth M.
Pinkiert, Danielle
Vilimas, Rasa J.
Thomas, Anish
机构：
[1] Temple Univ, Fox Chase Canc Ctr, Philadelphia, PA USA
[2] Natl Canc Ctr Hosp East, Shinjuku Ku, Kashiwa, Chiba, Japan
[3] AstraZeneca, Cambridge, England
[4] NCI, Dev Therapeut Branch, Ctr Canc Res, Bethesda, MD USA
[5] NIH, Bethesda, MD USA
[6] NCI, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS8130
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan
    Tiseo, Marcello
    But, Sebastiano
    Boni, Luca
    Mattioni, Roberto
    Ardizzoni, Andrea
    LUNG CANCER, 2014, 86 (01) : 91 - 95
  • [42] Retrospective analysis of combination chemotherapy with pembrolizumab and cytotoxic agents in elderly patients with non-small cell lung cancer
    Ohnishi, Hiroshi
    Takamatsu, Kazufumi
    Yamane, Mayuka
    Iwabu, Naomi
    Tsukuda, Tsukie
    Ogino, Yoshitaka
    Umeshita, Emi
    Mizuta, Junya
    Oyama, Kosuke
    Nakatani, Yu
    Ito, Takehiko
    Nishimori, Akari
    Terada, Junki
    Hirakawa, Yoshiaki
    RESPIROLOGY, 2024, 29 : 51 - 52
  • [43] Topotecan as salvage therapy of refractory small cell lung cancer
    Hatabay, Nilgun
    Erdal, Nuray
    Ece, Ferah
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S813 - S813
  • [44] Therapy of small cell lung cancer with emphasis on oral topotecan
    Pirker, Robert
    Berzinec, Peter
    Brincat, Stephen
    Kasan, Peter
    Ostoros, Gyula
    Pesek, Milos
    Plate, Signe
    Purkalne, Gunta
    Rooneem, Regina
    Skrickova, Jana
    Stanculeanu, Dana
    Timcheva, Constanta
    Tzekova, Valentina
    Zakotnik, Branko
    Zielinski, Christoph C.
    Zwitter, Matjaz
    LUNG CANCER, 2010, 70 (01) : 7 - 13
  • [45] Topotecan in the treatment of non-small cell lung cancer
    Perez-Soler, R
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S34 - S41
  • [46] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [47] The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer
    Alexander, Mariam
    Ko, Brian
    Lambert, Remy
    Gadgeel, Shirish
    Halmos, Balazs
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 137 - 147
  • [48] CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
    Cheng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S530 - S530
  • [49] Topotecan (Hycamtin®) in the therapy of small-cell lung cancer
    Manegold, C
    ONKOLOGIE, 1998, 21 : 13 - 17
  • [50] CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
    Cheng, Y.
    Liu, Y.
    Xin, Y.
    Zhu, J.
    Cui, H.
    Zhang, L.
    Wang, Y.
    Zhang, Q.
    Wei, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S379 - S379
12345